Corporate Venture: More Important, More Strategic
This article was originally published in Start Up
Executive Summary
In our third annual Life Science Venture Survey, corporate investors said they continue to focus on providing crucial capital to early-stage companies. They also reported this year that they’re being judged less strictly for the financial return they bring to their parent companies.